4
Changes in Ownership
Allogene Therapeutics, Inc. Filed Acc 0001209191-19-019758
Director acquired 115,333 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Belldegrun Arie Director | 2019-03-13 | Grant or award | +115,333 | 150,333 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Belldegrun Arie Director | 2019-03-13 | Grant or award · Stock Option (Right to Buy) | +195,133 | 195,133 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…